HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China · Delayed Price · Currency is CNY 3.620
+0.010 (0.28%)
Apr 29, 2026, 3:04 PM CST
SHE:002437 Revenue
HARBIN GLORIA PHARMACEUTICALS Co., LTD had revenue of 539.11M CNY in the quarter ending March 31, 2026, a decrease of -2.20%. This brings the company's revenue in the last twelve months to 2.12B, down -11.49% year-over-year. In the year 2025, HARBIN GLORIA PHARMACEUTICALS Co., LTD had annual revenue of 2.14B, down -12.51%.
Revenue (ttm)
2.12B
Revenue Growth
-11.49%
P/S Ratio
3.80
Revenue / Employee
785.54K
Employees
2,703
Market Cap
8.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.14B | -305.28M | -12.51% |
| Dec 31, 2024 | 2.44B | -185.31M | -7.06% |
| Dec 31, 2023 | 2.63B | -481.91M | -15.51% |
| Jan 1, 2023 | 3.11B | -37.37M | -1.19% |
| Jan 1, 2022 | 3.15B | 90.36M | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.50B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Shandong Lukang Pharmaceutical | 5.71B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Jiangsu Kanion Pharmaceutical | 3.29B |
| Jiuzhitang | 2.23B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Guangxi Wuzhou Zhongheng Group | 1.75B |